Pancreatic Cancer Research

GrantZIANCI Division of Basic Sciences (intramural)

DNA Repair in Human Cancer-Prone Genetic Diseases

Activity
ZIA
Institute
NCI Division of Basic Sciences (intramural)
Fiscal years counted
2024
Amount counted
$1,099,456

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Abstract public domain (NIH RePORTER)

1. XERODERMA PIGMENTOSUM (XP) We have been examining XP patients at NIH since 1971. We performed long term follow-up studies of cancer, hearing loss, of eye abnormalities and gynecological health in XP patients. Dr John DiGiovanna, M.D., senior research physician and long-term member of our group, died of pancreatic cancer in 2023. I retired at the end of December 2023 and the laboratory has closed. The protocols have closed to new patients and are only available for data analysis. The samples of blood, skin and hair collected from the study subjects have been transferred to a laboratory in DCEG, NCI. Major findings of our studies are the XP patients under age 20 years had a 10,000-fold increased risk of non-melanoma skin cancer (NMSK) and a 2000-fold increased risk of melanoma. In our natural history protocol, we ascertained and intensively examined more than 100 XP or Cockayne Syndrome (CS) patients and more than 200 family members at NIH. We published detailed autopsy reports of 4 XP patients - including the first autopsy of an XP-D patient. The XP-A and XP-D patients were adults with severe neurological degeneration and were found to have infant sized brains. We found that peripheral neuropathy types differed between the XP-A and XP-D patients. We identified mutations in all of the 9 currently known DNA nucleotide excision repair (NER) genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, ERCC1 and TTDA), in the error-prone polymerase, pol eta and in TTDN1 in nearly 200 XP or TTD patients. These studies have enabled us to identify some remarkable XP patients and better characterize different mechanisms of DNA repair. For example, we found XPC patients with splice lariat branch point mutations who had 3 to 5% of XPC mRNA but mild disease indicating that only a small amount of XPC is sufficient for some cancer protection. We found that the melanomas and nevi in the XP patients were different from those in the general population both clinically and histologically. They had a high proportion of mutations in the PTEN tumor suppressor gene (90% UV type), a lower frequency of mutations in BRAF, NRAS or KIT and rarely had the BRAF V600E mutation found in the general population. Our investigation of Big Data in the gnomAD database of more than 200,000 alleles revealed an unexpectedly high frequency of 2 XP causing missense variants, suggesting that there may be thousands of patients who are homozygous for these XP causing mutations in the US. Unsuspected mutations in known genes with a predisposition for skin cancer may be responsible for some of the high frequency of skin cancers in the general population. It is possible that variants in other genes modify the phenotype so that the usual features of XP are not apparent. We found that many of the women with mutations in the XPC gene have premature menopause (median age 29 years, 20 years earlier that in the general population) a feature of premature aging. We found hematologic malignancies in 4 young (18 to 36 years) XP patients with mutations in the XPC gene. XP patients have increased frequency of thyroid nodules at an early age. We performed a retrospective survey of XP patients seen at NIH who subsequently developed metastatic cancers and were treated with immune checkpoint inhibitors by their local doctors. We found that these patients had a good response with a similar frequency of side effects as in the general population. 2. TRICHOTHIODYSTROPHY (TTD) In contrast to the profound environmental influence of sun exposure on XP, TTD is a disease of altered development. In our natural history protocol, we ascertained and intensively examined more than 50 TTD or XP/TTD patients and more than110 TTD family members. This is the largest cohort of patients with this rare disorder in the world.

Abstract public domain (NIH RePORTER)

There was a high frequency of gestational abnormalities in pregnancies resulting in TTD affected offspring compared to pregnancies resulting in unaffected offspring from the same mothers or to the general population. These pregnancy complications were present only in pregnancies that had XP-D mutations that resulted in TTD offspring but not in XP-D mutations resulting in XP offspring. These observations provide important insights into the role of DNA repair genes in human pregnancy and fetal development. Infantile cataracts were present in more than half of the TTD patients. Several young children with TTD have lost the ability to walk due to aseptic necrosis of the femoral head. Unfortunately, surgical treatment was followed by a series of post-operative complications leading to death. We identified 12 XP/TTD patients who have features of both XP and TTD and increased cancer risk. In collaboration with colleagues in Italy, we identified mutations in a transcription associated gene (GTF2E2) as causing TTD in two patients. This closely links TTD to transcription defects rather than DNA repair defects.